Hilton Small-MidCap Opportunity ETF
SMCO - ETF AI Analysis
Top Page
Hilton Small-MidCap Opportunity ETF (SMCO)
SMCO, the Hilton Small-MidCap Opportunity ETF, appears to be a solid but not top-tier fund, supported by strong holdings like HealthEquity, Cullen/Frost Bankers, Steris, and EQT, which all show robust financial performance and positive earnings outlooks. However, weaker names such as IdaCorp and Radnet, which face revenue growth, cash flow, profitability, and leverage challenges, along with several holdings showing bearish or cautious technical signals and high valuations, hold back the overall rating and highlight the main risk: exposure to smaller companies where momentum and valuation can quickly shift.
SMCO vs. SPDR S&P 500 ETF (SPY)
- AUM
- 147.93M
- Region
- North America
- Expense Ratio
- 0.55%
- Beta
- 0.83
- Issuer
- Hilton
- Inception Date
- Nov 29, 2023
- Dividend Yield
- 0.95%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
SMCO Summary
SMCO, the Hilton Small-MidCap Opportunity ETF, focuses on smaller and mid-sized U.S. companies rather than the big household-name giants, and it does not track a specific index. It spreads investments across many sectors, including industrials, technology, and health care. Some of its well-known holdings include West Pharmaceutical Services and BJ’s Wholesale Club. An investor might choose SMCO to seek long-term growth and add diversification beyond large-cap stocks. However, smaller companies can be more volatile, so the ETF’s value can go up and down more sharply than the overall market.
How much will it cost me?
This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 invested. That’s higher than the average index ETF because SMCO is actively managed, focusing on carefully selected small- and mid-cap stocks rather than simply tracking a broad market index.
What would affect this ETF?
SMCO could benefit if the U.S. economy stays healthy, supporting growth in smaller industrial, technology, and health care companies, and if innovation and business spending increase in these areas. On the downside, higher interest rates, an economic slowdown, or sector-specific issues in areas like energy, financials, or its key holdings such as Healthequity and West Pharmaceutical Services could hurt performance, as small- and mid-cap stocks tend to be more sensitive to market stress.
SMCO Top 10 Holdings
SMCO leans into U.S. small and mid-caps, with a noticeable tilt toward industrials, health care, and tech. Tenable Holdings has been the fund’s spark plug lately, rising sharply and giving the ETF a growth-oriented feel. West Pharmaceutical and Clean Harbors are also climbing steadily, reinforcing the health care and industrial backbone. Teledyne and EQT add more industrial and energy flavor, with generally rising but occasionally mixed momentum. Steris, however, has been lagging, acting as a mild brake on performance rather than a full-on drag.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Healthequity | 2.67% | $3.98M | $8.56B | 3.98% | 76Outperform | |
| Cullen/Frost Bankers | 2.50% | $3.74M | $9.84B | 28.47% | 77Outperform | |
| Teledyne Technologies | 2.50% | $3.73M | $29.64B | 27.37% | 71Outperform | |
| Steris | 2.45% | $3.65M | $25.67B | 1.49% | 77Outperform | |
| West Pharmaceutical Services | 2.38% | $3.55M | $29.01B | 56.16% | 68Neutral | |
| IdaCorp | 2.37% | $3.53M | $8.63B | 13.42% | 64Neutral | |
| EQT | 2.33% | $3.48M | $33.04B | -12.35% | 76Outperform | |
| Magnite | 2.33% | $3.47M | $4.20B | 105.83% | 68Neutral | |
| Radnet | 2.20% | $3.29M | $6.02B | 4.03% | 63Neutral |
SMCO Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMCO, the sentiment is Neutral. The current price of 28.43 is above the 20-day moving average (MA) of 28.22, above the 50-day MA of 28.10, and below the 200-day MA of 28.97, indicating a neutral trend. The MACD of 0.09 indicates Negative momentum. The RSI at 52.64 is Neutral, neither overbought nor oversold. The STOCH value of 79.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SMCO.
SMCO Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $28.43 | $31.00(9.06% Upside) | $147.93M | 0.55% | 68Neutral | |
| $27.97 | $34.47(23.22% Upside) | $742.36M | 0.75% | 68Neutral | |
| $58.09 | $72.95(25.57% Upside) | $701.86M | 0.62% | 64Neutral | |
| $32.65 | $42.44(29.98% Upside) | $418.69M | 0.38% | 71Outperform | |
| $25.06 | $38.05(51.83% Upside) | $407.32M | 0.75% | 69Neutral | |
| $40.34 | $48.81(20.99% Upside) | $276.66M | 0.55% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SMCO | Hilton Small-MidCap Opportunity ETF | 28.43 | 2.89 | 11.31% | |
| RSMC | Rockefeller U.S. Small-Mid Cap ETF | 27.97 | 3.34 | 13.56% | |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | 58.09 | 10.27 | 21.47% | |
| ASCE | Allspring SMID Core ETF | 32.65 | 7.59 | 30.30% | |
| GRNJ | Fundstrat Granny Shots US Small- & Mid-Cap ETF | 25.06 | 0.76 | 3.13% | |
| SMIZ | Zacks Small/Mid Cap ETF | 40.34 | 4.66 | 13.06% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
